APICHOPE Trademark
Trademark Overview
On Wednesday, March 6, 2024, a trademark application was filed for APICHOPE with the United States Patent and Trademark Office. The USPTO has given the APICHOPE trademark a serial number of 79393489. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, October 23, 2024. This trademark is owned by ApicHope Pharmaceutical Co., Ltd. The APICHOPE trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for human purposes, for the treatment of infectious disease; medicines for human purposes, for the treatment of diabetes; medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; medicines for human purposes, for the treatment of hyperuricemia, gout; medicines for human purposes, for the treatment of autoimmune disorders; medicines for human purposes, for the treatment of cancer; medicines for human purposes, for the treatment of cardiovascular disease; medicines for human purposes for the treatment of respiratory system diseases; pharmaceutical preparations for the treatment of infectious disease; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; pharmaceutical preparations for the treatment of hyperuricemia, gout; pharmace...
General Information
| Serial Number | 79393489 |
| Word Mark | APICHOPE |
| Filing Date | Wednesday, March 6, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, October 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medicines for human purposes, for the treatment of infectious disease; medicines for human purposes, for the treatment of diabetes; medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; medicines for human purposes, for the treatment of hyperuricemia, gout; medicines for human purposes, for the treatment of autoimmune disorders; medicines for human purposes, for the treatment of cancer; medicines for human purposes, for the treatment of cardiovascular disease; medicines for human purposes for the treatment of respiratory system diseases; pharmaceutical preparations for the treatment of infectious disease; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; pharmaceutical preparations for the treatment of hyperuricemia, gout; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of respiratory system diseases |
| Pseudo Mark | APIC HOPE |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 17, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ApicHope Pharmaceutical Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
Trademark Events
| Event Date | Event Description |
| Thursday, April 11, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, April 15, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Wednesday, April 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, September 19, 2024 | ASSIGNED TO EXAMINER |
| Friday, September 27, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, September 28, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, October 2, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, October 2, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, October 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, October 19, 2024 | REFUSAL PROCESSED BY IB |
